| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.797 | 0.002 | 0.797 | Aromatase inhibitor | 0.231 0.007 CID_128210 | ||
| 0.735 | 0.006 | 0.885 | Cholesterol antagonist | 0.885 0.003 CID_128210 | CID_128210 | |
| 0.749 | 0.023 | 0.86 | Antiinflammatory | 0.86 0.008 CID_128210 | CID_128210 | |
| 0.715 | 0.019 | 0.894 | Transcription factor NF kappa B inhibitor | 0.894 0.007 CID_128210 | CID_128210 | |
| 0.723 | 0.027 | 0.748 | Apoptosis agonist | 0.748 0.023 CID_128210 | CID_128210 | |
| 0.654 | 0.012 | 0.654 | Aldehyde oxidase inhibitor | |||
| 0.593 | 0.002 | 0.593 | Androgen agonist | 0.223 0.004 CID_128210 | ||
| 0.619 | 0.034 | 0.619 | Caspase 9 stimulant | 0.546 0.046 CID_128210 | ||
| 0.588 | 0.004 | 0.59 | Interleukin 2 agonist | 0.59 0.004 CID_128210 | CID_128210 | |
| 0.593 | 0.01 | 0.691 | Nitric oxide antagonist | 0.691 0.006 CID_128210 | CID_128210 | |
| 0.554 | 0.004 | 0.554 | Estrogen antagonist | 0.207 0.012 CID_128210 | ||
| 0.554 | 0.01 | 0.554 | Hypoxia-inducible factor 1 alpha inhibitor | 0.499 0.015 CID_128210 | ||
| 0.546 | 0.003 | 0.546 | Estrogen agonist | 0.324 0.005 CID_128210 | ||
| 0.531 | 0.025 | 0.614 | Immunosuppressant | 0.614 0.011 CID_128210 | CID_128210 | |
| 0.508 | 0.004 | 0.508 | Lipocortins synthesis antagonist | 0.417 0.007 CID_128210 | ||
| 0.497 | 0.008 | 0.497 | Anesthetic general | 0.494 0.008 CID_128210 | ||
| 0.469 | 0.001 | 0.469 | 5-Alpha-reductase 1 inhibitor | 0.123 0.004 CID_128210 | ||
| 0.467 | 0.005 | 0.467 | Sodium/bile acid cotransporter inhibitor | 0.405 0.015 CID_128210 | ||
| 0.468 | 0.009 | 0.634 | Diuretic | 0.634 0.004 CID_128210 | CID_128210 | |
| 0.462 | 0.005 | 0.462 | Interleukin 6 antagonist | 0.393 0.008 CID_128210 | ||
| 0.449 | 0.002 | 0.449 | Estradiol 17 beta-dehydrogenase inhibitor | |||
| 0.473 | 0.032 | 0.473 | 5 Hydroxytryptamine release stimulant | 0.259 0.085 CID_128210 | ||
| 0.441 | 0.009 | 0.54 | Interferon gamma antagonist | 0.54 0.004 CID_128210 | CID_128210 | |
| 0.442 | 0.014 | 0.598 | Interleukin agonist | 0.598 0.005 CID_128210 | CID_128210 | |
| 0.425 | 0.001 | 0.425 | 5-Alpha-reductase 2 inhibitor | 0.226 0.003 CID_128210 | ||
| 0.425 | 0.001 | 0.425 | RNA-directed RNA polymerase stimulant | 0.237 0.003 CID_128210 | ||
| 0.411 | 0.002 | 0.411 | Estradiol 17 beta-dehydrogenase 3 inhibitor | |||
| 0.41 | 0.005 | 0.41 | Androgen antagonist | 0.074 0.073 CID_128210 | ||
| 0.404 | 0.001 | 0.404 | Anabolic | 0.221 0.003 CID_128210 | ||
| 0.404 | 0.002 | 0.404 | 5-Alpha-reductase inhibitor | 0.297 0.003 CID_128210 | ||
| 0.437 | 0.04 | 0.657 | Immunostimulant | 0.657 0.011 CID_128210 | CID_128210 | |
| 0.392 | 0.006 | 0.392 | Neurotrophic factor enhancer | 0.355 0.009 CID_128210 | ||
| 0.383 | 0.005 | 0.383 | Cholesterol synthesis inhibitor | 0.336 0.008 CID_128210 | ||
| 0.362 | 0.004 | 0.362 | Estrogen receptor alpha antagonist | |||
| 0.342 | 0.002 | 0.342 | 3(or 17)beta-hydroxysteroid dehydrogenase inhibitor | 0.083 0.015 CID_128210 | ||
| 0.368 | 0.028 | 0.419 | Psychostimulant | 0.419 0.02 CID_128210 | CID_128210 | |
| 0.336 | 0.013 | 0.444 | NOS3 expression enhancer | 0.444 0.006 CID_128210 | CID_128210 | |
| 0.362 | 0.043 | 0.605 | Antioxidant | 0.605 0.011 CID_128210 | CID_128210 | |
| 0.321 | 0.003 | 0.321 | Estrogen receptor alpha agonist | 0.093 0.009 CID_128210 | ||
| 0.332 | 0.018 | 0.541 | Melanin inhibitor | 0.541 0.005 CID_128210 | CID_128210 | |
| 0.315 | 0.001 | 0.315 | Glucose-6-phosphate dehydrogenase inhibitor | 0.097 0.003 CID_128210 | ||
| 0.314 | 0.005 | 0.314 | Estrogen receptor beta antagonist | 0.098 0.068 CID_128210 | ||
| 0.341 | 0.04 | 0.609 | Tumour necrosis factor alpha release inhibitor | 0.609 0.007 CID_128210 | CID_128210 | |
| 0.321 | 0.024 | 0.525 | Hepatoprotectant | 0.525 0.006 CID_128210 | CID_128210 | |
| 0.289 | 0.004 | 0.289 | Estrogen receptor beta agonist | 0.162 0.006 CID_128210 | ||
| 0.281 | 0.003 | 0.281 | Arachidonic acid antagonist | 0.243 0.007 CID_128210 | ||
| 0.334 | 0.064 | 0.513 | Apoptosis antagonist | 0.513 0.019 CID_128210 | CID_128210 | |
| 0.262 | 0.004 | 0.262 | CDC25A inhibitor | 0.097 0.029 CID_128210 | ||
| 0.273 | 0.021 | 0.273 | Bone formation stimulant | 0.163 0.05 CID_128210 | ||
| 0.281 | 0.03 | 0.281 | Glyceraldehyde-3-phosphate dehydrogenase inhibitor | 0.16 0.126 CID_128210 | ||
| 0.294 | 0.046 | 0.446 | DNA synthesis inhibitor | 0.446 0.017 CID_128210 | CID_128210 | |
| 0.245 | 0.002 | 0.245 | Estradiol 17 beta-dehydrogenase 1 inhibitor | |||
| 0.276 | 0.038 | 0.276 | RNA-directed DNA polymerase inhibitor | 0.214 0.08 CID_128210 | ||
| 0.245 | 0.012 | 0.245 | Farnesoid X receptor antagonist | 0.134 0.075 CID_128210 | ||
| 0.286 | 0.055 | 0.738 | Angiogenesis stimulant | 0.738 0.004 CID_128210 | CID_128210 | |
| 0.228 | 0.003 | 0.327 | Glycine receptor antagonist | 0.327 0.002 CID_128210 | CID_128210 | |
| 0.217 | 0.004 | 0.217 | Progesterone antagonist | |||
| 0.239 | 0.028 | 0.239 | Acetylcholine M1 receptor antagonist | |||
| 0.215 | 0.007 | 0.215 | Keratolytic | |||
| 0.203 | 0.004 | 0.203 | Aldosterone antagonist | |||
| 0.205 | 0.011 | 0.205 | Interleukin 8 antagonist | |||
| 0.227 | 0.035 | 0.432 | Amylase inhibitor | 0.432 0.008 CID_128210 | CID_128210 | |
| 0.195 | 0.004 | 0.195 | Glycine receptor agonist | 0.167 0.005 CID_128210 | ||
| 0.214 | 0.024 | 0.221 | DNA polymerase I inhibitor | 0.221 0.023 CID_128210 | CID_128210 | |
| 0.207 | 0.018 | 0.247 | Microtubule formation inhibitor | 0.247 0.01 CID_128210 | CID_128210 | |
| 0.19 | 0.002 | 0.19 | Estrone sulfatase inhibitor | 0.094 0.005 CID_128210 | ||
| 0.253 | 0.067 | 0.496 | Free radical scavenger | 0.496 0.017 CID_128210 | CID_128210 | |
| 0.197 | 0.012 | 0.197 | Pregnane X receptor agonist | |||
| 0.288 | 0.104 | 0.288 | Calcium channel activator | |||
| 0.21 | 0.03 | 0.21 | Anesthetic local | |||
| 0.189 | 0.011 | 0.189 | Prolactin inhibitor | |||
| 0.254 | 0.077 | 0.254 | 5 Hydroxytryptamine uptake stimulant | |||
| 0.215 | 0.039 | 0.215 | Antipruritic | |||
| 0.21 | 0.038 | 0.21 | Phospholipase C inhibitor | 0.176 0.066 CID_128210 | ||
| 0.187 | 0.02 | 0.187 | Adenylate cyclase stimulant | 0.141 0.079 CID_128210 | ||
| 0.245 | 0.085 | 0.245 | Gastrin inhibitor | 0.2 0.149 CID_128210 | ||
| 0.164 | 0.004 | 0.204 | Na+ K+ transporting ATPase inhibitor | 0.204 0.002 CID_128210 | CID_128210 | |
| 0.239 | 0.079 | 0.239 | Tyrosine 3 hydroxylase inhibitor | |||
| 0.26 | 0.104 | 0.336 | Caspase 3 stimulant | 0.336 0.064 CID_128210 | CID_128210 | |
| 0.181 | 0.024 | 0.294 | Antineoplastic antibiotic | 0.294 0.01 CID_128210 | CID_128210 | |
| 0.193 | 0.044 | 0.297 | Lipid peroxidase inhibitor | 0.297 0.019 CID_128210 | CID_128210 | |
| 0.193 | 0.044 | 0.369 | Protein kinase stimulant | 0.369 0.01 CID_128210 | CID_128210 | |
| 0.208 | 0.059 | 0.208 | P-glycoprotein inhibitor | 0.181 0.079 CID_128210 | ||
| 0.233 | 0.098 | 0.233 | Transcription factor STAT3 inhibitor | |||
| 0.165 | 0.039 | 0.168 | Aldehyde dehydrogenase inhibitor | 0.168 0.038 CID_128210 | CID_128210 | |
| 0.129 | 0.005 | 0.129 | Mineralocorticoid receptor antagonist | 0.044 0.04 CID_128210 | ||
| 0.125 | 0.004 | 0.125 | Glucocorticoid antagonist | 0.062 0.011 CID_128210 | ||
| 0.127 | 0.007 | 0.127 | Estrogen-related receptor beta agonist | |||
| 0.119 | 0.003 | 0.119 | Lipocortins synthesis agonist | 0.109 0.004 CID_128210 | ||
| 0.152 | 0.037 | 0.152 | Ca2+-transporting ATPase inhibitor | 0.148 0.048 CID_128210 | ||
| 0.116 | 0.003 | 0.116 | Progesterone agonist | 0.034 0.006 CID_128210 | ||
| 0.222 | 0.11 | 0.222 | Transcription factor STAT inhibitor | |||
| 0.127 | 0.015 | 0.127 | Bile acid receptor antagonist | 0.089 0.076 CID_128210 | ||
| 0.152 | 0.044 | 0.152 | Adenylate cyclase inhibitor | 0.109 0.077 CID_128210 | ||
| 0.108 | 0.003 | 0.108 | Pregnane X receptor antagonist | 0.053 0.05 CID_128210 | ||
| 0.109 | 0.005 | 0.109 | Heme oxygenase stimulant | 0.076 0.019 CID_128210 | ||
| 0.156 | 0.054 | 0.156 | Neurotrophic factor | 0.143 0.066 CID_128210 | ||
| 0.207 | 0.11 | 0.207 | DNA damaging | 0.204 0.112 CID_128210 | ||
| 0.11 | 0.02 | 0.11 | Beta tubulin antagonist | |||
| 0.158 | 0.07 | 0.158 | Protein-tyrosine phosphatase inhibitor | 0.134 0.097 CID_128210 | ||
| 0.251 | 0.163 | 0.251 | 15-Lipoxygenase inhibitor | |||
| 0.177 | 0.091 | 0.177 | Growth factor agonist | |||
| 0.122 | 0.042 | 0.172 | Toll-Like receptor 4 antagonist | 0.172 0.012 CID_128210 | CID_128210 | |
| 0.134 | 0.054 | 0.271 | Monophenol monooxygenase inhibitor | 0.271 0.021 CID_128210 | CID_128210 | |
| 0.084 | 0.005 | 0.084 | Steroid 17-alpha-hydroxylase/17,20 lyase inhibitor | |||
| 0.121 | 0.043 | 0.275 | UDP-glucose 4-epimerase inhibitor | 0.275 0.012 CID_128210 | CID_128210 | |
| 0.132 | 0.054 | 0.139 | Protein-tyrosine phosphatase 1B inhibitor | 0.139 0.05 CID_128210 | CID_128210 | |
| 0.121 | 0.044 | 0.121 | DOPA decarboxylase inhibitor | |||
| 0.111 | 0.038 | 0.111 | ABCA1 expression enhancer | |||
| 0.106 | 0.038 | 0.106 | Ornithine decarboxylase inhibitor | 0.082 0.066 CID_128210 | ||
| 0.07 | 0.006 | 0.07 | 11-Beta-hydroxysteroid dehydrogenase 2 inhibitor | 0.064 0.006 CID_128210 | ||
| 0.13 | 0.071 | 0.13 | Tubulin antagonist | |||
| 0.098 | 0.04 | 0.098 | Carbonic anhydrase VI inhibitor | |||
| 0.123 | 0.065 | 0.201 | Alkylator | 0.201 0.026 CID_128210 | CID_128210 | |
| 0.112 | 0.056 | 0.23 | AMP-activated protein kinase stimulant | 0.23 0.008 CID_128210 | CID_128210 | |
| 0.155 | 0.103 | 0.155 | Succinate dehydrogenase inhibitor | |||
| 0.056 | 0.004 | 0.056 | Glucocorticoid agonist | 0.017 0.008 CID_128210 | ||
| 0.253 | 0.202 | 0.253 | Calcium channel L-type activator | |||
| 0.08 | 0.031 | 0.08 | HIV-1 integrase (Strand Transfer) inhibitor | |||
| 0.104 | 0.055 | 0.104 | Creatine kinase inhibitor | |||
| 0.073 | 0.024 | 0.073 | GABA receptor antagonist | |||
| 0.064 | 0.015 | 0.064 | Adenylate cyclase 1 inhibitor | |||
| 0.051 | 0.003 | 0.051 | Corticosteroid-like | 0.043 0.004 CID_128210 | ||
| 0.117 | 0.07 | 0.117 | Acetylcholine muscarinic antagonist | |||
| 0.084 | 0.039 | 0.084 | Lipase inhibitor | |||
| 0.156 | 0.114 | 0.156 | Interleukin antagonist | |||
| 0.043 | 0.001 | 0.043 | Transcortin receptor antagonist | 0.008 0.003 CID_128210 | ||
| 0.043 | 0.004 | 0.043 | Hedgehog signaling activator | |||
| 0.114 | 0.076 | 0.114 | Acetylcholine antagonist | |||
| 0.116 | 0.078 | 0.116 | Cholinergic antagonist | |||
| 0.221 | 0.183 | 0.221 | GABA C receptor rho-3 antagonist | |||
| 0.232 | 0.195 | 0.626 | Antibacterial | 0.626 0.016 CID_128210 | CID_128210 | |
| 0.106 | 0.07 | 0.106 | Cystathionine beta-synthase inhibitor | |||
| 0.064 | 0.028 | 0.064 | Alpha tubulin antagonist | |||
| 0.052 | 0.016 | 0.052 | Dopamine D5 agonist | |||
| 0.092 | 0.058 | 0.103 | Glutamate release inhibitor | 0.103 0.038 CID_128210 | CID_128210 | |
| 0.056 | 0.024 | 0.056 | Potassium channel Kv1.3 blocker | |||
| 0.086 | 0.053 | 0.086 | Inducible nitric-oxide synthase inhibitor | |||
| 0.088 | 0.056 | 0.088 | Antineoplastic alkaloid | |||
| 0.069 | 0.038 | 0.069 | CDC25B inhibitor | |||
| 0.074 | 0.043 | 0.074 | HIV-1 integrase inhibitor | |||
| 0.114 | 0.084 | 0.202 | Alpha-N-acetylglucosaminidase inhibitor | 0.202 0.033 CID_128210 | CID_128210 | |
| 0.048 | 0.018 | 0.048 | GABA uptake inhibitor | |||
| 0.143 | 0.114 | 0.395 | Platelet adhesion inhibitor | 0.395 0.012 CID_128210 | CID_128210 | |
| 0.03 | 0.003 | 0.044 | Telomerase stimulant | 0.044 0.002 CID_128210 | CID_128210 | |
| 0.097 | 0.07 | 0.097 | GABA C receptor agonist | |||
| 0.054 | 0.027 | 0.054 | 11-Beta-hydroxysteroid dehydrogenase 1 inhibitor | |||
| 0.05 | 0.028 | 0.06 | Microtubule stabilization | 0.06 0.015 CID_128210 | CID_128210 | |
| 0.056 | 0.034 | 0.056 | GABA A receptor antagonist | |||
| 0.023 | 0.002 | 0.023 | 3 Beta-hydroxy-delta 5-steroid dehydrogenase inhibitor | 0.014 0.006 CID_128210 | ||
| 0.079 | 0.059 | 0.079 | Opioid kappa receptor antagonist | |||
| 0.027 | 0.01 | 0.031 | Dopamine D1 agonist | 0.031 0.008 CID_128210 | CID_128210 | |
| 0.082 | 0.066 | 0.157 | Transcription factor NF kappa B stimulant | 0.157 0.014 CID_128210 | CID_128210 | |
| 0.055 | 0.041 | 0.055 | Argininosuccinate synthase inhibitor | |||
| 0.149 | 0.135 | 0.149 | Insulin sensitizer | |||
| 0.039 | 0.025 | 0.039 | Farnesoid X receptor agonist | |||
| 0.017 | 0.004 | 0.017 | Progesterone receptor A antagonist | |||
| 0.04 | 0.03 | 0.04 | Liver X receptor alpha agonist | |||
| 0.023 | 0.014 | 0.023 | Vitamin D receptor antagonist | 0.023 0.014 CID_128210 | ||
| 0.064 | 0.055 | 0.064 | Glutamate (mGluR6) antagonist | |||
| 0.033 | 0.026 | 0.033 | Tubulin agonist | |||
| 0.051 | 0.044 | 0.051 | Alcohol oxidase inhibitor | |||
| 0.035 | 0.03 | 0.035 | 2,3-Oxidosqualene-lanosterol cyclase inhibitor | |||
| 0.016 | 0.012 | 0.016 | Vitamin D receptor agonist | 0.016 0.013 CID_128210 | ||
| 0.055 | 0.053 | 0.055 | HIV-1 integrase (3'-Processing) inhibitor | |||
| 0.018 | 0.017 | 0.018 | Progesterone receptor B antagonist | |||
| 0.092 | 0.091 | 0.092 | GABA C receptor antagonist | |||
| 0.021 | 0.03 | 0.035 | Vanilloid 2 agonist | 0.035 0.006 CID_128210 | CID_128210 | |
| 0.091 | 0.108 | 0.134 | Photosensitizer | 0.134 0.042 CID_128210 | CID_128210 | |
| 0.009 | 0.03 | 0.033 | Ileal bile acid transport inhibitor | 0.033 0.005 CID_128210 | CID_128210 | |
| 0.049 | 0.07 | 0.118 | Phosphofructokinase-1 inhibitor | 0.118 0.026 CID_128210 | CID_128210 | |
| 0.146 | 0.169 | 0.209 | Spasmolytic | 0.209 0.112 CID_128210 | CID_128210 | |
| 0.038 | 0.061 | 0.055 | Glucose-6-phosphate isomerase inhibitor | 0.055 0.023 CID_128210 | CID_128210 | |
| 0.08 | 0.112 | 0.152 | Beta glucuronidase inhibitor | 0.152 0.024 CID_128210 | CID_128210 | |
| 0.073 | 0.109 | 0.212 | Expectorant | 0.212 0.018 CID_128210 | CID_128210 | |
| 0.012 | 0.052 | 0.022 | Antibiotic Anthracycline-like | 0.022 0.008 CID_128210 | CID_128210 | |
| 0.171 | 0.218 | 0.551 | Antithrombotic | 0.551 0.022 CID_128210 | CID_128210 | |
| 0.113 | 0.161 | 0.146 | CC chemokine 6 receptor antagonist | 0.146 0.029 CID_128210 | CID_128210 | |
| 0.084 | 0.133 | 0.236 | Cyclooxygenase 3 inhibitor | 0.236 0.01 CID_128210 | CID_128210 | |
| 0.065 | 0.12 | 0.108 | NADH dehydrogenase inhibitor | 0.108 0.036 CID_128210 | CID_128210 | |
| 0.064 | 0.12 | 0.113 | Triose-phosphate isomerase inhibitor | 0.113 0.037 CID_128210 | CID_128210 | |
| 0.064 | 0.123 | 0.087 | UDP-N-acetylglucosamine 1-carboxyvinyltransferase inhibitor | 0.087 0.069 CID_128210 | CID_128210 | |
| 0.012 | 0.077 | 0.05 | Protein 30S ribosomal subunit inhibitor | 0.05 0.008 CID_128210 | CID_128210 | |
| 0.114 | 0.184 | 0.26 | Hypolipemic | 0.26 0.063 CID_128210 | CID_128210 | |
| 0.026 | 0.098 | 0.102 | Protein 50S ribosomal subunit inhibitor | 0.102 0.013 CID_128210 | CID_128210 | |
| 0.03 | 0.113 | 0.071 | Alpha-mannosidase inhibitor | 0.071 0.016 CID_128210 | CID_128210 | |
| 0.094 | 0.193 | 0.293 | Hemostatic | 0.293 0.016 CID_128210 | CID_128210 | |
| 0.038 | 0.14 | 0.104 | Topoisomerase II alpha inhibitor | 0.104 0.037 CID_128210 | CID_128210 | |
| 0.012 | 0.117 | 0.028 | 1,3-Beta-glucan synthase inhibitor | 0.028 0.021 CID_128210 | CID_128210 | |
| 0.029 | 0.142 | 0.093 | Heparanase inhibitor | 0.093 0.004 CID_128210 | CID_128210 | |
| 0.114 | 0.236 | 0.179 | Cyclic AMP phosphodiesterase inhibitor | 0.179 0.112 CID_128210 | CID_128210 | |
| 0.017 | 0.146 | 0.057 | Mannosidase inhibitor | 0.057 0.019 CID_128210 | CID_128210 | |
| 0.025 | 0.16 | 0.06 | Nitric oxide donor | 0.06 0.048 CID_128210 | CID_128210 | |
| 0.028 | 0.168 | 0.064 | Neuraminidase (influenza) inhibitor | 0.064 0.044 CID_128210 | CID_128210 | |
| 0.093 | 0.235 | 0.184 | Non-steroidal antiinflammatory agent | 0.184 0.084 CID_128210 | CID_128210 | |
| 0.007 | 0.155 | 0.035 | Sodium/glucose cotransporter 2 inhibitor | 0.035 0.01 CID_128210 | CID_128210 | |
| 0.095 | 0.255 | 0.245 | Vasodilator | 0.245 0.072 CID_128210 | CID_128210 | |
| 0.178 | 0.347 | 0.269 | 5 Hydroxytryptamine release inhibitor | 0.269 0.203 CID_128210 | CID_128210 | |
| 0.073 | 0.247 | 0.167 | Hexokinase inhibitor | 0.167 0.06 CID_128210 | CID_128210 | |
| 0.038 | 0.218 | 0.111 | Mediator release inhibitor | 0.111 0.057 CID_128210 | CID_128210 | |
| 0.008 | 0.198 | 0.03 | Sodium/glucose cotransporter inhibitor | 0.03 0.011 CID_128210 | CID_128210 | |
| 0.047 | 0.243 | 0.105 | Multidrug resistance-associated protein 1 inhibitor | 0.105 0.07 CID_128210 | CID_128210 | |
| 0.032 | 0.229 | 0.056 | Adenine nucleotide translocase inhibitor | 0.056 0.038 CID_128210 | CID_128210 | |
| 0.037 | 0.236 | 0.14 | Topoisomerase II inhibitor | 0.14 0.055 CID_128210 | CID_128210 | |
| 0.131 | 0.331 | 0.263 | Histamine release inhibitor | 0.263 0.146 CID_128210 | CID_128210 | |
| 0.03 | 0.232 | 0.159 | Topoisomerase I inhibitor | 0.159 0.038 CID_128210 | CID_128210 | |
| 0.114 | 0.323 | 0.272 | Vasodilator, coronary | 0.272 0.112 CID_128210 | CID_128210 | |
| 0.071 | 0.297 | 0.136 | DNA repair enzyme inhibitor | 0.136 0.047 CID_128210 | CID_128210 | |
| 0.106 | 0.338 | 0.37 | Immunomodulator | 0.37 0.053 CID_128210 | CID_128210 | |
| 0.021 | 0.271 | 0.069 | Glucose-6-phosphate translocase inhibitor | 0.069 0.016 CID_128210 | CID_128210 | |
| 0.071 | 0.403 | 0.541 | Hypoglycemic | 0.541 0.012 CID_128210 | CID_128210 | |
| 0.039 | 0.377 | 0.152 | Cell wall synthesis inhibitor | 0.152 0.064 CID_128210 | CID_128210 | |
| 0.063 | 0.403 | 0.168 | ATPase inhibitor | 0.168 0.073 CID_128210 | CID_128210 | |
| 0.022 | 0.364 | 0.061 | Factor III inhibitor | 0.061 0.017 CID_128210 | CID_128210 | |
| 0.049 | 0.412 | 0.199 | Insulin secretagoues | 0.199 0.036 CID_128210 | CID_128210 | |
| 0.014 | 0.389 | 0.068 | Antibiotic Aminoglycoside-like | 0.068 0.006 CID_128210 | CID_128210 | |
| 0.009 | 0.393 | 0.308 | Selectin antagonist | 0.308 0.005 CID_128210 | CID_128210 | |
| 0.081 | 0.53 | 0.676 | Cyclophilin D inhibitor | 0.676 0.017 CID_128210 | CID_128210 | |
| 0.086 | 0.543 | 0.356 | Peptidyltransferase inhibitor | 0.356 0.011 CID_128210 | CID_128210 | |
| 0.011 | 0.47 | 0.029 | Toll-Like receptor 4 agonist | 0.029 0.013 CID_128210 | CID_128210 | |
| 0.023 | 0.508 | 0.084 | Thioredoxin inhibitor | 0.084 0.074 CID_128210 | CID_128210 | |
| 0.015 | 0.596 | 0.219 | Thrombolytic | 0.219 0.043 CID_128210 | CID_128210 | |
| 0.018 | 0.601 | 0.189 | Platelet antagonist | 0.189 0.11 CID_128210 | CID_128210 | |
| 0.013 | 0.627 | 0.1 | ATPase (Vacuolar H+) inhibitor | 0.1 0.039 CID_128210 | CID_128210 | |
| 0.013 | 0.735 | 0.148 | Cell adhesion inhibitor | 0.148 0.048 CID_128210 | CID_128210 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |